IPD awarded with €50.000,= grant from KansenvoorWest
I want to thank Rob Blank, from SIRA incentives, again for his ongoing support and making this happen. Also province of Zuid-Holland, European Union and EFRO for offering their support to start-ups like IPD. We WILL make a difference in treating patients with the devastating complication of prosthetic joint infection. Grateful to NLC health ventures, […]
Exciting Opportunity: Head of Product Development at Implant Preservation Devices (IPD) 🚀
IPD are on a mission to revolutionize how prosthetic joint and fracture-related infections are treated. Their groundbreaking technology, developed in collaboration with experts from Leiden University Medical Center, uses induction heating to remove biofilms and bacterial colonies from implants, offering a game-changing solution for patients. CEO Richard van de Wateringen is now looking for a […]
IPD and Hedon Electronic development awarded with MIT collaboration grant
IPD, https://ipd.health and #Hedon Electronics development awarded with MIT collaboration grant of €200k from province of Zuid-Holland, The Netherlands to develop and expand the portfolio to trauma applications. A big thank you also for Rob Blank, #SIRA Incentives for their ongoing support! IPD develops an anti-bacterial implant heating device to treat Orthopaedic Prosthetic Joint and […]
IPD uses Ansys engineering simulation software
For more than 50 years, Ansys software has enabled innovators across industries to push boundaries with the predictive power of simulation. From sustainable transportation and advanced semiconductors, to satellite systems and life-saving medical devices, the next great leaps in human advancement will be powered by Ansys. WWW.ANSYS.COM/STARTUPS
Induction technology presented at ATiO meeting in Berlin.
I want to thank the Alliance for Advanced Therapies in Orthopaedics Conference 2023 held in Berlin, #ATiO, for giving IPD the opportunity to present our technology by prof. dr. Rob Nelissen Nelissen from LUMC Leiden to a great audience.
IPD CEO Richard van de Wateringen and Prof.dr. R.Nelissen presented at the EFORT 2023 meeting in Vienna
At #efort2023 congres in Vienna, prof.dr. Rob Nelissen and Richard van de Wateringen, CEO IPD, had the pleasure to present IPD (https://ipd.health), the non-contact induction technology to treat PJI (an innovation by Rob Nelissen and Bart Pijls), during the symposium “From idea to innovation to safe bed-side application: Venture building for innovation.
Orthopaedic department LUMC meets IPD shareholders
Last week IPD and the Orthopaedic department LUMC, Leiden had the honour and pleasure to host the clinical meeting in LUMC Leiden for shareholders of IPD (https://ipd.health).Rob Nelissen, Bart Pijls and Bart Kaptein presented in an interactive way their expertise and solution to treat Orthopaedic and metal implant infections. A devastating complication after joint replacement. Dr. Robert-Jan Vreeburg , Conor Simpson, MSc […]
IPD secures funding of €2.100.000 to initiate its clinical study for treating hip implant infections.
IPD B.V. (Implant Preservation Devices), a Dutch startup specialising in the treatment of prosthetic joint infections, raised €2.1 million in its seeding round, which closed Friday July 14th 2023. The money will be used for the final development of its revolutionary device and its first-in-human clinical study involving patients with infection of their hip implant. The study is […]
Rabobank Innovation Loan for IPD
Rabobank invests in startup companies with promising technologies. IPD has been granted the RIL for an amount of €150.000,= to continue our journey with the innovation, from prof. dr. Rob Nelissen and dr. B.Pijls, of non-contact induction heating to treat prosthetic and metal implant infections. I want to thank Rabobank for their trust and confidence in IPD.
€ 350.000 voor betere behandeling implantaat-infecties door Leidse startup Implant Preservation Devices
€ 𝟑𝟓𝟎.𝟎𝟎𝟎,- 𝐯𝐨𝐨𝐫 𝐛𝐞𝐭𝐞𝐫𝐞 𝐛𝐞𝐡𝐚𝐧𝐝𝐞𝐥𝐢𝐧𝐠 𝐯𝐚𝐧 𝐢𝐦𝐩𝐥𝐚𝐧𝐭𝐚𝐚𝐭-𝐢𝐧𝐟𝐞𝐜𝐭𝐢𝐞𝐬 𝐝𝐨𝐨𝐫 𝐋𝐞𝐢𝐝𝐬𝐞 𝐬𝐭𝐚𝐫𝐭𝐮𝐩 𝐈𝐦𝐩𝐥𝐚𝐧𝐭 𝐏𝐫𝐞𝐬𝐞𝐫𝐯𝐚𝐭𝐢𝐨𝐧 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 / Bij 1-3% van de gewrichtsvervangende operaties gaat het implantaat infecteren. Dat vormt een enorme belasting voor zowel patiënt als de wereldwijde gezondheidszorg. Huidige behandelingen van die infecties hebben verschillende negatieve implicaties – meerdere operaties, langdurig ziekenhuisverblijf en langdurig gebruik van antibiotica […]